PCI logo from eps file.jpg
PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series
November 08, 2021 05:15 ET | PCI Biotech Holding ASA
Oslo (Norway), 8 November 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the coordinating principal investigator for the RELEASE trial, Prof. Dr. Jörg...
PCI logo from eps file.jpg
PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer
May 28, 2021 08:51 ET | PCI Biotech Holding ASA
Oslo, 28 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has granted Orphan Drug...
logo.jpg
PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
October 26, 2020 07:48 ET | PCI Biotech Holding ASA
Oslo (Norway), 26 October 2020 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...